Kaplan-Meier Plotter survival analysis suggested that breast cancer patients with low expression of USP53 had significantly worse overall survival (OS, Fig. 2D) and relapse free survival (RFS, Fig. 2E) than those with high expression. Here, USP53 is linked to breast carcinoma.